Erik J. M. Toonen

2.2k total citations
44 papers, 1.0k citations indexed

About

Erik J. M. Toonen is a scholar working on Immunology, Rheumatology and Epidemiology. According to data from OpenAlex, Erik J. M. Toonen has authored 44 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 12 papers in Rheumatology and 10 papers in Epidemiology. Recurrent topics in Erik J. M. Toonen's work include Complement system in diseases (11 papers), Rheumatoid Arthritis Research and Therapies (11 papers) and Cytokine Signaling Pathways and Interactions (5 papers). Erik J. M. Toonen is often cited by papers focused on Complement system in diseases (11 papers), Rheumatoid Arthritis Research and Therapies (11 papers) and Cytokine Signaling Pathways and Interactions (5 papers). Erik J. M. Toonen collaborates with scholars based in Netherlands, Germany and Hungary. Erik J. M. Toonen's co-authors include Marieke J. H. Coenen, Pilar Barrera, Leo A. B. Joosten, Cees J. Tack, Andreea-Manuela Mirea, Triantafyllos Chavakis, Piet L. C. M. van Riel, Hans Scheffer, Barbara Franke and Wim H.A. Dokter and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Erik J. M. Toonen

43 papers receiving 993 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erik J. M. Toonen Netherlands 20 342 253 234 223 112 44 1.0k
Kiyoki Kitagawa Japan 18 429 1.3× 222 0.9× 312 1.3× 102 0.5× 91 0.8× 35 1.5k
Wen‐Chan Tsai Taiwan 20 466 1.4× 514 2.0× 248 1.1× 135 0.6× 106 0.9× 82 1.3k
Tünde Tarr Hungary 19 573 1.7× 754 3.0× 230 1.0× 129 0.6× 118 1.1× 61 1.4k
Huiping Chen China 20 153 0.4× 207 0.8× 273 1.2× 117 0.5× 87 0.8× 56 1.2k
Mária Filková Czechia 20 330 1.0× 518 2.0× 422 1.8× 377 1.7× 67 0.6× 49 1.5k
Noriyoshi Ogawa Japan 23 532 1.6× 372 1.5× 307 1.3× 236 1.1× 192 1.7× 81 1.6k
Benjamin A. Fisher United Kingdom 22 425 1.2× 474 1.9× 231 1.0× 184 0.8× 158 1.4× 66 1.6k
Nabil Mtiraoui Tunisia 24 240 0.7× 213 0.8× 268 1.1× 143 0.6× 222 2.0× 52 1.2k
Masayuki Iyoda Japan 18 313 0.9× 141 0.6× 278 1.2× 66 0.3× 74 0.7× 69 1.2k
Michelle J. Ormseth United States 20 185 0.5× 373 1.5× 368 1.6× 116 0.5× 36 0.3× 42 1.1k

Countries citing papers authored by Erik J. M. Toonen

Since Specialization
Citations

This map shows the geographic impact of Erik J. M. Toonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik J. M. Toonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik J. M. Toonen more than expected).

Fields of papers citing papers by Erik J. M. Toonen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik J. M. Toonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik J. M. Toonen. The network helps show where Erik J. M. Toonen may publish in the future.

Co-authorship network of co-authors of Erik J. M. Toonen

This figure shows the co-authorship network connecting the top 25 collaborators of Erik J. M. Toonen. A scholar is included among the top collaborators of Erik J. M. Toonen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik J. M. Toonen. Erik J. M. Toonen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brandwijk, Ricardo, et al.. (2025). Complement function and activation in human serum and plasma collected in different blood collection tubes. Journal of Immunological Methods. 538. 113825–113825. 1 indexed citations
2.
Toonen, Erik J. M., et al.. (2025). Novel antibodies and assays to ascertain the role of C4 protein variants in Schizophrenia risk. Immunobiology. 230(4). 152950–152950.
3.
Davies, Helen, Kristin Ladell, Kelly L. Miners, et al.. (2024). Complement dysregulation is a prevalent and therapeutically amenable feature of long COVID. Med. 5(3). 239–253.e5. 25 indexed citations
4.
Kajdácsi, Erika, László Cervenak, Zoltán Prohászka, et al.. (2024). Storage of Transfusion Platelet Concentrates Is Associated with Complement Activation and Reduced Ability of Platelets to Respond to Protease-Activated Receptor-1 and Thromboxane A2 Receptor. International Journal of Molecular Sciences. 25(2). 1091–1091. 4 indexed citations
5.
Mescia, Federica, Laura Bergamaschi, Erika Kajdácsi, et al.. (2024). sMR and PTX3 levels associate with COVID-19 outcome and survival but not with Long COVID. iScience. 27(7). 110162–110162. 3 indexed citations
6.
Toonen, Erik J. M., Bettina Sarg, Leopold Kremser, et al.. (2024). Complement C7 and clusterin form a complex in circulation. Frontiers in Immunology. 15. 1330095–1330095. 5 indexed citations
7.
Troldborg, Anne, Erik J. M. Toonen, Zoltán Prohászka, et al.. (2023). Differentiating between activation via the lectin or the classical complement pathway in patients with systemic lupus erythematosus. Clinical & Experimental Immunology. 214(1). 18–25. 2 indexed citations
8.
Mescia, Federica, Shaghayegh Bayati, Peter Heeringa, et al.. (2023). Autoantibody Profiling and Anti-Kinesin Reactivity in ANCA-Associated Vasculitis. International Journal of Molecular Sciences. 24(20). 15341–15341. 3 indexed citations
9.
Kotsaki, Antigone, Matthijs Kox, Peter Pickkers, et al.. (2023). Complement activation in severely ill patients with sepsis: no relationship with inflammation and disease severity. Critical Care. 27(1). 63–63. 14 indexed citations
10.
Toonen, Erik J. M., Erika Kajdácsi, Ricardo Brandwijk, et al.. (2022). Distinction of early complement classical and lectin pathway activation via quantification of C1s/C1-INH and MASP-1/C1-INH complexes using novel ELISAs. Frontiers in Immunology. 13. 1039765–1039765. 20 indexed citations
11.
Jorge, Elena Goicoechea de, Mihály Józsi, Antje J. Baeumner, et al.. (2022). Evaluating the clinical utility of measuring levels of factor H and the related proteins. Molecular Immunology. 151. 166–182. 9 indexed citations
12.
Schäfer, Nicole, Ricardo Brandwijk, Erik J. M. Toonen, et al.. (2019). Oxidative Stress Increases Endogenous Complement-Dependent Inflammatory and Angiogenic Responses in Retinal Pigment Epithelial Cells Independently of Exogenous Complement Sources. Antioxidants. 8(11). 548–548. 33 indexed citations
13.
Toonen, Erik J. M., Theo H. van Dijk, Aycha Bleeker, et al.. (2014). Glucose Kinetics in the Collagen-Induced Arthritis Model: An All-in-One Model to Assess Both Efficacy and Metabolic Side Effects of Glucocorticoids. PLoS ONE. 9(9). e98684–e98684. 6 indexed citations
14.
Fleuren, Wilco, Erik J. M. Toonen, Stefan Verhoeven, et al.. (2013). Identification of new biomarker candidates for glucocorticoid induced insulin resistance using literature mining. BioData Mining. 6(1). 2–2. 4 indexed citations
15.
Toonen, Erik J. M., Christian Gilissen, Barbara Franke, et al.. (2012). Validation Study of Existing Gene Expression Signatures for Anti-TNF Treatment in Patients with Rheumatoid Arthritis. PLoS ONE. 7(3). e33199–e33199. 49 indexed citations
16.
Coenen, Marieke J. H., Judith A.M. Wessels, Sita H. Vermeulen, et al.. (2011). Genome-Wide Association Analysis of Rheumatoid Arthritis Patients Treated with Anti-TNF Medication. Data Archiving and Networked Services (DANS). 63(10). 1 indexed citations
17.
Linssen, Margot M., Daniël H. van Raalte, Erik J. M. Toonen, et al.. (2011). Prednisolone-induced beta cell dysfunction is associated with impaired endoplasmic reticulum homeostasis in INS-1E cells. Cellular Signalling. 23(11). 1708–1715. 52 indexed citations
18.
Coenen, Marieke J. H., Christian Enevold, Pilar Barrera, et al.. (2010). Genetic Variants in Toll-Like Receptors Are Not Associated with Rheumatoid Arthritis Susceptibility or Anti-Tumour Necrosis Factor Treatment Outcome. PLoS ONE. 5(12). e14326–e14326. 25 indexed citations
19.
Frijters, Raoul, Wilco Fleuren, Erik J. M. Toonen, et al.. (2010). Prednisolone-induced differential gene expression in mouse liver carrying wild type or a dimerization-defective glucocorticoid receptor. BMC Genomics. 11(1). 359–359. 93 indexed citations
20.
Toonen, Erik J. M., Pilar Barrera, TRDJ Radstake, et al.. (2008). Gene expression profiling in rheumatoid arthritis: current concepts and future directions. Annals of the Rheumatic Diseases. 67(12). 1663–1669. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026